Analysts project the robotic surgery leader’s valuation to more than triple from its current $150 billion on strong growth prospects.
Intuitive Surgical’s market capitalization could surge to $500 billion by 2031, up from $150 billion, driven by its dominant position in robotic surgery. The company’s Da Vinci systems lead the global market, with deep integration in hospitals and surgeon training programs.
The firm has released five generations of its flagship system since 2000, reinforcing its competitive moat. Hospitals and surgeons favor the platform due to high switching costs and familiarity, supporting long-term growth.
Intuitive Surgical’s consistent revenue expansion and leadership in minimally invasive procedures underpin the optimistic outlook.